Abstract | BACKGROUND: OBJECTIVE: We aimed to investigate the frequencies of aluminum allergy when ACH and AL were used in patch testing consecutive patients. METHODS:
Petrolatum preparations of ACH 10.0% and AL 12.0% were added to the baseline series in 2010-2017. Aluminum chloride hexahydrate 10.0% pet was added to the children baseline series from July 1, 2012, to December 31, 2017. RESULTS: A total of 5448 patients were patch tested with the extended baseline series and 196 children with the extended children baseline series. Forty-eight of the 5448 adults (0.9%) and 10 of the 196 children (5.1%) were diagnosed with aluminum contact allergy. A significant difference was found between the aluminum allergy frequencies in children and adults patch tested with ACH in 2013-2017 (P < 0.001). The difference between the frequencies of contact allergies for the 2 aluminum salts is not statistically significant. CONCLUSIONS: Patch testing with ACH and AL demonstrated similar contact allergy frequencies. To detect aluminum allergy, patch testing with ACH 10.0% pet is recommended. Aluminum chloride hexahydrate 10.0% pet should be considered for inclusion in baseline series for patch testing adults and children.
|
Authors | Ingrid Siemund, Jakob Dahlin, Monica Hindsén, Erik Zimerson, Annarita Antelmi, Nils Hamnerius, Inese Hauksson, Marléne Isaksson, Ann Pontén, Martin Mowitz, Cecilia Svedman, Magnus Bruze |
Journal | Dermatitis : contact, atopic, occupational, drug
(Dermatitis)
2022 Jan-Feb 01
Vol. 33
Issue 1
Pg. 31-35
ISSN: 2162-5220 [Electronic] United States |
PMID | 34570735
(Publication Type: Journal Article)
|
Copyright | Copyright © 2021 American Contact Dermatitis Society. All Rights Reserved. |
Chemical References |
- Allergens
- Aluminum Compounds
- Aluminum Chloride
|
Topics |
- Adult
- Age Factors
- Allergens
(administration & dosage, adverse effects)
- Aluminum Chloride
(administration & dosage, adverse effects)
- Aluminum Compounds
(adverse effects)
- Child
- Dermatitis, Allergic Contact
(diagnosis, etiology)
- Female
- Humans
- Intradermal Tests
(methods)
- Male
- Patch Tests
(methods)
- Risk Factors
|